The investment, which is expected to be complete by 2030, will boost U.S. production of Roche’s continuous glucose monitoring tools.
Roche to invest up to $550M in Midwest manufacturing site
view original post
The investment, which is expected to be complete by 2030, will boost U.S. production of Roche’s continuous glucose monitoring tools.